| Authors: |
Tesch ME; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Zheng Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Guzman-Arocho YD; Beth Israel Deaconess Medical Center, Massachusetts., Collins LC; Beth Israel Deaconess Medical Center, Massachusetts., Heng YJ; Beth Israel Deaconess Medical Center, Massachusetts., Tayob N; Harvard Medical School, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Rosenberg SM; Weill Cornell Medicine, New York, New York., Ruddy KJ; Mayo Clinic, Rochester, Minnesota., Tamimi RM; Weill Cornell Medicine, New York, New York., Schapira L; Stanford Cancer Institute, Stanford, California., Peppercorn J; Massachusetts General Hospital, Boston, Massachusetts., Borges V; University of Colorado Cancer Center, Denver, Colorado., Come SE; Beth Israel Deaconess Medical Center, Massachusetts., Snow C; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Winer EP; Yale Cancer Center, New Haven, Connecticut., Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts. |
